Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Moderna Announces Supply Agreement with the UK for Additional 60 Million Doses of Moderna’s COVID-19 Vaccine in 2022 and 2023
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]
Aelis Farma Announces Good Results From its First Administration in Humans for AEF0217, its First Drug Candidate for the Treatment of Cognitive Disorders in Down Syndrome
AELIS FARMA, a biotechnology company specializing in the treatment of brain disorders, announces today that AEF0217 […]
Roche Has Rapidly Developed Additional Testing Options to Differentiate Mutations in the Omicron SARS-CoV-2 Variant
Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a newly acquired subsidiary within the Roche […]
Acumen Diagnostics' PCR Capabilities to Tackle Omicron COVID-19 Variant
Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. (“Acumen Diagnostics” or the “Company”), a 51% […]
EverImmune Raises €5M to Enter Clinical Phase in Microbiota Immuno-oncology
EverImmune, a biotechnology company specialized in the development of live biotherapeutic products in the field […]
Northwest Biotherapeutics Announces $15 Million Financing
Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor […]
On Target Laboratories Announces FDA Approval of CYTALUX ™ (pafolacianine) Injection for Identification of Ovarian Cancer During Surgery
On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and […]
JOYSBIO's SARS-COV-2 Antigen Rapid Test Detects OMICRON Variant
JOYSBIO, one of the world’s leading manufacturers of lateral flow rapid tests, is proud to […]
NovAliX Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries
NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces its […]
Cue Health Confirms COVID-19 Tests Can Detect Omicron Variant
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has completed an analysis […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more